Predicting disease-related genes by topological similarity in human protein-protein interaction network

Predicting genes likely to be involved in human diseases is an important task in bioinformatics field. Nowadays, the accumulation of human protein-protein interactions (PPIs) data provides us an unprecedented opportunity to gain insight into human diseases. In this paper, we adopt the topological similarity in human protein-protein interaction network to predict disease-related genes. As a computational algorithm to speed up the identification of disease-related genes, the topological similarity has substantial advantages over previous topology-based algorithms. First of all, it provides a global measurement of similarity between two vertices. Secondly, quantity which can measure new topological feature has been integrated into the notion of topological similarity. Our method is specially designed for predicting disease-related genes of single disease-gene family. The proposed method is applied to human protein-protein interaction and hepatocellular carcinoma (HCC) data. The results show a significant enrichment of disease-related genes that are characterized by higher topological similarity than other genes.

[1]  M. Newman,et al.  Vertex similarity in networks. , 2005, Physical review. E, Statistical, nonlinear, and soft matter physics.

[2]  K. N. Chandrika,et al.  Analysis of the human protein interactome and comparison with yeast, worm and fly interaction datasets , 2006, Nature Genetics.

[3]  David Wynford-Thomas,et al.  REVIEW ARTICLE. p53: GUARDIAN OF CELLULAR SENESCENCE , 1996 .

[4]  Yongjin Li,et al.  Discovering disease-genes by topological features in human protein-protein interaction network , 2006, Bioinform..

[5]  M Eck,et al.  The chemokine receptor CCR7 is expressed on epithelium of non‐inflamed gastric mucosa, Helicobacter pylori gastritis, gastric carcinoma and its precursor lesions and up‐regulated by H. pylori , 2005, Clinical and experimental immunology.

[6]  E. Gehan,et al.  Activation of Signal Transducer and Activator of Transcription-5 in Prostate Cancer Predicts Early Recurrence , 2005, Clinical Cancer Research.

[7]  S. Fields,et al.  A novel genetic system to detect protein–protein interactions , 1989, Nature.

[8]  Sheung Tat Fan,et al.  Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition. , 2006, Cancer research.

[9]  Ines Gockel,et al.  Chemokine receptor CCR7 enhances intrahepatic and lymphatic dissemination of human hepatocellular cancer. , 2006, Oncology reports.

[10]  J. Herman,et al.  SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity , 2001, Nature Genetics.

[11]  B. Snel,et al.  Predicting disease genes using protein–protein interactions , 2006, Journal of Medical Genetics.

[12]  M. Snyder,et al.  Proteomics: Protein complexes take the bait , 2002, Nature.

[13]  Xin He,et al.  PIK3IP1, a negative regulator of PI3K, suppresses the development of hepatocellular carcinoma. , 2008, Cancer research.

[14]  P. Kemmeren,et al.  A new web-based data mining tool for the identification of candidate genes for human genetic disorders , 2003, European Journal of Human Genetics.

[15]  Akinori Iwasaki,et al.  Association between the expression of chemokine receptors CCR7 and CXCR3, and lymph node metastatic potential in lung adenocarcinoma. , 2008, Oncology reports.

[16]  Wen-Hui Su,et al.  OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci , 2006, Nucleic Acids Res..

[17]  Ting Chen,et al.  Further understanding human disease genes by comparing with housekeeping genes and other genes , 2006, BMC Genomics.

[18]  Manabu Fukumoto,et al.  Kan‐1 (Bile acid CoA:Amino acid N‐acyltransferase) messenger RNA as a novel predictive indicator for prognosis of hepatocellular carcinoma patients after partial hepatectomy , 1996 .

[19]  C. Ouzounis,et al.  Genome-wide identification of genes likely to be involved in human genetic disease. , 2004, Nucleic acids research.

[20]  A. Marilyn Leitch,et al.  DNA Methylation in Benign Breast Epithelium in Relation to Age and Breast Cancer Risk , 2008, Cancer Epidemiology Biomarkers & Prevention.

[21]  Mitchell L. Drumm,et al.  Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer , 1990, Cell.

[22]  David W. Yandell,et al.  A point mutation of the rhodopsin gene in one form of retinitis pigmentosa , 1990, Nature.

[23]  Z. Ling,et al.  Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma. , 2009, World journal of gastroenterology.

[24]  S. Kondo,et al.  Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors , 2008, Oncogene.

[25]  Robert E. Ferrell,et al.  Decreased STAT1 Expression by Promoter Methylation in Squamous Cell Carcinogenesis , 2007 .

[26]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[27]  H. Yasuda,et al.  Involvement of PIAS1 in the sumoylation of tumor suppressor p53. , 2001, Molecular cell.

[28]  G. E. Davis,et al.  A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis , 2001, Apoptosis.

[29]  Takeshi Tokuhisa,et al.  Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation , 2002, The Journal of experimental medicine.

[30]  Igor Jurisica,et al.  Online Predicted Human Interaction Database , 2005, Bioinform..

[31]  Alan Cantor,et al.  Activation of Stat3 in Primary Tumors from High-Risk Breast Cancer Patients Is Associated with Elevated Levels of Activated Src and Survivin Expression , 2006, Clinical Cancer Research.

[32]  R. Sharan,et al.  Protein networks in disease. , 2008, Genome research.